Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
By How Much Is The Tumor Ablation Therapy Devices Market Expected To Expand Between 2025 And 2029?
The market for tumor ablation therapy apparatus experienced swift expansion lately, projected to ascend from a valuation of $0.72 billion in 2024 to $0.82 billion the following year, which constitutes a compound annual growth rate of 14.2%; this upward trajectory throughout the past period is fundamentally supported by increasing cancer occurrences, progress in technology, the demographic shift towards an older populace, and the rising preference for less invasive medical interventions.
Anticipation surrounds the tumor ablation therapy devices sector, projecting substantial expansion ahead; by 2029, the market is forecast to reach a valuation of $1.42 billion, driven by a cumulative annual growth rate (CAGR) of 14.6%, this upward trajectory is fueled by developments such as tailored medical treatments, the application of combined therapeutic approaches, the integration of artificial intelligence with image-guided ablation techniques, the rise of virtual healthcare and remote patient assessments, alongside focused efforts in professional instruction and learning, whereas prevailing trends shaping this period involve progress in ablation methodologies, enhancement of imaging assistance, utilization of robotic systems and navigation support, the merging of ablation with immuno-oncology strategies, and the increasing use of minimally invasive, image-guided ablation procedures.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3351&type=smp
What Are The Main Drivers Boosting The Tumor Ablation Therapy Devices Industry’s Expansion?
The expanding incidence of cancer serves as a primary impetus for the expansion within the tumor ablation therapy devices market. Given that cancer claims the lives of approximately one in every six individuals globally, it stands as the second leading cause of mortality worldwide. Tumor ablation, a procedure distinguished by its minimally invasive nature, finds extensive application in managing malignancies affecting the lungs, liver, kidneys, and bones. To illustrate this trend, projections from the American Cancer Society Inc., a US-based charitable health organization, indicated an anticipated 1,958,310 new cancer diagnoses in the US for 2023, marking an uptick from the over 1,918,030 new cases identified in 2022. Furthermore, because this technique offers an efficacious alternative for patients for whom chemotherapy or radiotherapy has proven unsuccessful, it actively contributes to the upward trajectory of the market for tumor ablation therapy devices.
What Are The Major Segment Categories Driving The Tumor Ablation Therapy Devices Market Growth?
The tumor ablation therapy devicesmarket covered in this report is segmented –
1) By Technology: Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation, Other Technologies
2) By Treatment: Surgical, Laparoscopic, Percutaneous
3) By Application: Kidney Cancer, Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer, Other Applications
4) By End User: Hospitals, Oncology Clinics, Other End Users
Subsegments:
1) By Radiofrequency Ablation (RFA): Monopolar RFA Devices, Bipolar RFA Devices
2) By Microwave Ablation: High-frequency Microwave Devices, Low-frequency Microwave Devices
3) By Cryoablation: Liquid Nitrogen-based Devices, Argon Gas-based Devices
4) By Irreversible Electroporation Ablation (IRE): NanoKnife Ablation Systems, High-voltage Pulse Generators
5) By Other Technologies: Laser Ablation Devices, Ultrasound-guided High-intensity Focused Ultrasound (HIFU), Chemical Ablation Techniques
Which Key Trends Are Expected To Influence The Tumor Ablation Therapy Devices Market In The Coming Years?
Market leaders within the tumor ablation therapy device sector are currently concentrating their efforts on technological progress aimed at achieving quicker treatment times, enhanced patient safety profiles, reduced reliance on radiation exposure, accelerated skill acquisition among practitioners, and superior therapeutic results.Specifically, J&J Medicals introduced NEUWAVE, a microwave ablation platform that stands out as the inaugural minimally invasive instrument capable of inserting probes directly into malignant cells to elevate the local temperature, thereby inducing thermal destruction of the cancerous tissue.As an illustration, in the spring of 2023, the Taiwanese electronics manufacturer Compal Electronics unveiled AblatePal, a novel radiofrequency ablation (RFA) apparatus engineered for the purpose of coagulating and destroying soft tissue through the skin or during surgery, notably providing partial or total therapy for liver lesions that cannot be surgically removed.The operational principle of this device involves utilizing thermal energy generated by electrical resistance as an electrical current is channeled through the biological tissue, resulting in the elimination of the designated target areas.This system is incorporated into therapeutic medical equipment and has been developed to manage diverse medical issues, with a significant focus on oncological applications.
Who Are The Top Performing Companies In The Tumor Ablation Therapy Devices Market In Recent Years?
Major companies operating in the tumor ablation therapy devices market include Galil Medical Inc., Misonix Inc., HealthTronics Inc., AngioDynamics Inc., Boston Scientific Corporation, Medtronic plc, EDAP TMS S.A., NeuWave Medical Inc., BVM Medical Limited, Erbe Elektromedizin GmbH, AtriCure Inc., Theraclion, INTIO Inc., BIOTRONIK SE & Co. KG, Olympus Corporation, Stryker Corporation, Merit Medical Systems Inc., Insightec Ltd., Terumo Corporation, Smith & Nephew plc, Monteris Medical Corporation, IceCure Medical Ltd., Profound Medical Inc., Alpinion Medical Systems Co. Ltd., Sonacare Medical, Hologic Inc., Endocare Inc., Integra LifeSciences Corporation, Bovie Medical Corporation
Download The Full Report For Exclusive Market Findings:
Which Regional Markets Are Contributing Most To The Tumor Ablation Therapy Devices Industry Expansion?
North America was the largest region in the tumor ablation therapy devices market in 2024. Asia-Pacific was the second largest region in the tumor ablation therapy devices market. The regions covered in the tumor ablation therapy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Request A Customized Version Of The Tumor Ablation Therapy Devices Market Report:
https://www.thebusinessresearchcompany.com/customise?id=3351&type=smp
Browse Through More Reports Similar to the Global Tumor Ablation Therapy Devices Market 2025, By The Business Research Company
Point Of Care Diagnostics Devices And Equipment Global Market Report 2025
Psoriasis Drugs Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/psoriasis-drugs-global-market-report
Antibody Drug Conjugates Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/antibody-drug-conjugates-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model